José Fuentes Pradera

831 citations
15 papers · 45 indexed · h-index 4

José Fuentes Pradera

13 papers receiving 43 citations

Peers

José Fuentes Pradera
Comparison fields: 5 of 20
  • Otorhinolaryngology 9
  • Oncology 33
  • Pulmonary and Respiratory Medicine 28
  • Reproductive Medicine 6
  • Genetics 4
Replace N. Rozensztajn with:
N. Rozensztajn France
J.J. Lee United States
Marta Stachowiak Poland
Verónica Pereira United States
Jiyu Wen China
J. Yu China
Alexandra Carmel France
J. Marruecos Querol Spain
S. Marimuthu United States
Sarah Derby United Kingdom
José Fuentes Pradera relative to N. Rozensztajn France N. Rozensztajn's profile →
Citations per field
00.5×10×14×
N. Rozensztajn · 1×
Citations per year

Countries citing papers authored by José Fuentes Pradera

Since Specialization
Citations

This map shows the geographic impact of José Fuentes Pradera's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by José Fuentes Pradera with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites José Fuentes Pradera more than expected).

Fields of papers citing papers by José Fuentes Pradera

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by José Fuentes Pradera. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by José Fuentes Pradera. The network helps show where José Fuentes Pradera may publish in the future.

Co-authorship network

The 25 scholars most cited alongside José Fuentes Pradera, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with José Fuentes Pradera Line = papers co-authored together José Fuentes Pradera links everyone, so they are left out of the graph.

All Works

15 of 15 papers shown
#Work
1 20250
2 20244
3 202412
4 20231
5 20231
6 20221
7 20201
8 20190
9 20197
10 20181
11 201812
12 20151
13 20141
14 20141
15 20112

About José Fuentes Pradera

José Fuentes Pradera is a scholar working on Oncology, Pulmonary and Respiratory Medicine and Reproductive Medicine, having authored 15 papers that have together received 45 indexed citations. Recurring topics across this work include Lung Cancer Treatments and Mutations (5 papers), Lung Cancer Research Studies (4 papers), PARP inhibition in cancer therapy (3 papers), Advanced Breast Cancer Therapies (2 papers), Gastric Cancer Management and Outcomes (2 papers), Ovarian cancer diagnosis and treatment (2 papers), Cancer Immunotherapy and Biomarkers (2 papers) and Cancer Diagnosis and Treatment (1 paper). The work is most often cited by research in Otorhinolaryngology (9 citations), Oncology (33 citations) and Pulmonary and Respiratory Medicine (28 citations). José Fuentes Pradera has collaborated with scholars based in Spain, United States and France. Frequent co-authors include José Antonio Irles Rocamora, Pedro Pablo García‐Luna, Fabrice Barlési, David Vicente, Pilar Serrano Aguayo, G. Robinet, Martin Reck, Ingel Demedts, Tony Mok and Federico Cappuzzo. Their work appears in journals such as Journal of Clinical Oncology, Annals of Oncology and Journal of Thoracic Oncology.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026